nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.121	1	CrCrCtD
Amitriptyline—ADRA2A—type 2 diabetes mellitus	0.0652	0.238	CbGaD
Amitriptyline—HTR2C—type 2 diabetes mellitus	0.06	0.219	CbGaD
Amitriptyline—CYP2E1—type 2 diabetes mellitus	0.0476	0.174	CbGaD
Amitriptyline—CYP1A2—type 2 diabetes mellitus	0.0453	0.165	CbGaD
Amitriptyline—CYP3A4—type 2 diabetes mellitus	0.03	0.109	CbGaD
Amitriptyline—ALB—type 2 diabetes mellitus	0.0261	0.0954	CbGaD
Amitriptyline—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0164	0.0434	CbGbCtD
Amitriptyline—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0144	0.038	CbGbCtD
Amitriptyline—ORM1—Nateglinide—type 2 diabetes mellitus	0.0134	0.0352	CbGbCtD
Amitriptyline—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0132	0.0347	CbGbCtD
Amitriptyline—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0126	0.0333	CbGbCtD
Amitriptyline—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0126	0.0333	CbGbCtD
Amitriptyline—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0119	0.0313	CbGbCtD
Amitriptyline—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.00918	0.0242	CbGbCtD
Amitriptyline—ALB—Gliclazide—type 2 diabetes mellitus	0.00872	0.023	CbGbCtD
Amitriptyline—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.00838	0.0221	CbGbCtD
Amitriptyline—ALB—Repaglinide—type 2 diabetes mellitus	0.0082	0.0216	CbGbCtD
Amitriptyline—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00793	0.0209	CbGbCtD
Amitriptyline—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0079	0.0208	CbGbCtD
Amitriptyline—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.00755	0.0199	CbGbCtD
Amitriptyline—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.00755	0.0199	CbGbCtD
Amitriptyline—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.00724	0.0191	CbGbCtD
Amitriptyline—DRD2—Bromocriptine—type 2 diabetes mellitus	0.00696	0.0184	CbGbCtD
Amitriptyline—ALB—Rosiglitazone—type 2 diabetes mellitus	0.00685	0.0181	CbGbCtD
Amitriptyline—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00634	0.0167	CbGbCtD
Amitriptyline—ALB—Valsartan—type 2 diabetes mellitus	0.00605	0.016	CbGbCtD
Amitriptyline—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00602	0.0159	CbGbCtD
Amitriptyline—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00573	0.0151	CbGbCtD
Amitriptyline—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00566	0.0149	CbGbCtD
Amitriptyline—ALB—Nateglinide—type 2 diabetes mellitus	0.00562	0.0148	CbGbCtD
Amitriptyline—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00553	0.0146	CbGbCtD
Amitriptyline—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00537	0.0142	CbGbCtD
Amitriptyline—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00529	0.014	CbGbCtD
Amitriptyline—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00511	0.0135	CbGbCtD
Amitriptyline—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00506	0.0133	CbGbCtD
Amitriptyline—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00481	0.0127	CbGbCtD
Amitriptyline—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00481	0.0127	CbGbCtD
Amitriptyline—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0047	0.0124	CbGbCtD
Amitriptyline—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00452	0.0119	CbGbCtD
Amitriptyline—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00444	0.0117	CbGbCtD
Amitriptyline—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00429	0.0113	CbGbCtD
Amitriptyline—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00417	0.011	CbGbCtD
Amitriptyline—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0041	0.0108	CbGbCtD
Amitriptyline—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.004	0.0105	CbGbCtD
Amitriptyline—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.004	0.0105	CbGbCtD
Amitriptyline—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00388	0.0102	CbGbCtD
Amitriptyline—ALB—Glyburide—type 2 diabetes mellitus	0.0038	0.01	CbGbCtD
Amitriptyline—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00369	0.00973	CbGbCtD
Amitriptyline—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00366	0.00964	CbGbCtD
Amitriptyline—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00361	0.00952	CbGbCtD
Amitriptyline—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00356	0.0094	CbGbCtD
Amitriptyline—ALB—Losartan—type 2 diabetes mellitus	0.00347	0.00916	CbGbCtD
Amitriptyline—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00337	0.0089	CbGbCtD
Amitriptyline—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00326	0.0086	CbGbCtD
Amitriptyline—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00322	0.0085	CbGbCtD
Amitriptyline—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00322	0.00848	CbGbCtD
Amitriptyline—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00305	0.00804	CbGbCtD
Amitriptyline—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00303	0.00799	CbGbCtD
Amitriptyline—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00294	0.00776	CbGbCtD
Amitriptyline—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00291	0.00766	CbGbCtD
Amitriptyline—CYP3A5—Losartan—type 2 diabetes mellitus	0.00279	0.00736	CbGbCtD
Amitriptyline—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00277	0.00731	CbGbCtD
Amitriptyline—CYP2C8—Losartan—type 2 diabetes mellitus	0.00268	0.00708	CbGbCtD
Amitriptyline—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00267	0.00703	CbGbCtD
Amitriptyline—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00266	0.00701	CbGbCtD
Amitriptyline—NTRK2—peripheral nervous system—type 2 diabetes mellitus	0.00262	0.0743	CbGeAlD
Amitriptyline—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00257	0.00678	CbGbCtD
Amitriptyline—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00246	0.00649	CbGbCtD
Amitriptyline—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00232	0.00613	CbGbCtD
Amitriptyline—CYP2C19—Losartan—type 2 diabetes mellitus	0.00225	0.00594	CbGbCtD
Amitriptyline—CYP1A2—Losartan—type 2 diabetes mellitus	0.00208	0.00548	CbGbCtD
Amitriptyline—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00205	0.0054	CbGbCtD
Amitriptyline—NTRK2—nerve—type 2 diabetes mellitus	0.00205	0.0579	CbGeAlD
Amitriptyline—ABCB1—Glyburide—type 2 diabetes mellitus	0.00199	0.00524	CbGbCtD
Amitriptyline—CYP2C9—Losartan—type 2 diabetes mellitus	0.00187	0.00494	CbGbCtD
Amitriptyline—ABCB1—Losartan—type 2 diabetes mellitus	0.00182	0.00479	CbGbCtD
Amitriptyline—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00176	0.00465	CbGbCtD
Amitriptyline—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00169	0.00446	CbGbCtD
Amitriptyline—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00169	0.00446	CbGbCtD
Amitriptyline—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0016	0.00421	CbGbCtD
Amitriptyline—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00128	0.0362	CbGeAlD
Amitriptyline—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00123	0.0349	CbGeAlD
Amitriptyline—HTR2A—arteriole—type 2 diabetes mellitus	0.00121	0.0342	CbGeAlD
Amitriptyline—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00119	0.00314	CbGbCtD
Amitriptyline—KCNA1—nerve—type 2 diabetes mellitus	0.00118	0.0335	CbGeAlD
Amitriptyline—CYP3A4—Losartan—type 2 diabetes mellitus	0.00109	0.00287	CbGbCtD
Amitriptyline—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.000861	0.0244	CbGeAlD
Amitriptyline—NTRK2—retina—type 2 diabetes mellitus	0.000847	0.024	CbGeAlD
Amitriptyline—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00083	0.0235	CbGeAlD
Amitriptyline—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00077	0.0218	CbGeAlD
Amitriptyline—NTRK2—cardiovascular system—type 2 diabetes mellitus	0.000717	0.0203	CbGeAlD
Amitriptyline—OPRM1—nerve—type 2 diabetes mellitus	0.000661	0.0187	CbGeAlD
Amitriptyline—NTRK2—adipose tissue—type 2 diabetes mellitus	0.000632	0.0179	CbGeAlD
Amitriptyline—HTR1B—artery—type 2 diabetes mellitus	0.00061	0.0173	CbGeAlD
Amitriptyline—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.000599	0.0169	CbGeAlD
Amitriptyline—HTR1D—artery—type 2 diabetes mellitus	0.000591	0.0167	CbGeAlD
Amitriptyline—KCND3—islet of Langerhans—type 2 diabetes mellitus	0.000571	0.0161	CbGeAlD
Amitriptyline—KCNQ3—cardiovascular system—type 2 diabetes mellitus	0.000543	0.0154	CbGeAlD
Amitriptyline—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000517	0.0146	CbGeAlD
Amitriptyline—KCNA1—retina—type 2 diabetes mellitus	0.00049	0.0139	CbGeAlD
Amitriptyline—SLC6A2—nerve—type 2 diabetes mellitus	0.000484	0.0137	CbGeAlD
Amitriptyline—HTR2A—hindlimb—type 2 diabetes mellitus	0.000479	0.0135	CbGeAlD
Amitriptyline—KCND2—cardiovascular system—type 2 diabetes mellitus	0.000473	0.0134	CbGeAlD
Amitriptyline—HTR7—artery—type 2 diabetes mellitus	0.000471	0.0133	CbGeAlD
Amitriptyline—HTR7—nerve—type 2 diabetes mellitus	0.000467	0.0132	CbGeAlD
Amitriptyline—DRD2—nerve—type 2 diabetes mellitus	0.000441	0.0125	CbGeAlD
Amitriptyline—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000439	0.0124	CbGeAlD
Amitriptyline—KCND2—adipose tissue—type 2 diabetes mellitus	0.000417	0.0118	CbGeAlD
Amitriptyline—KCND3—cardiovascular system—type 2 diabetes mellitus	0.000413	0.0117	CbGeAlD
Amitriptyline—KCND3—pancreas—type 2 diabetes mellitus	0.000401	0.0114	CbGeAlD
Amitriptyline—HTR7—endothelium—type 2 diabetes mellitus	0.000397	0.0112	CbGeAlD
Amitriptyline—KCND3—cortex of kidney—type 2 diabetes mellitus	0.000393	0.0111	CbGeAlD
Amitriptyline—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000373	0.0106	CbGeAlD
Amitriptyline—KCND3—adipose tissue—type 2 diabetes mellitus	0.000364	0.0103	CbGeAlD
Amitriptyline—OPRD1—kidney—type 2 diabetes mellitus	0.000332	0.00941	CbGeAlD
Amitriptyline—HRH2—cardiovascular system—type 2 diabetes mellitus	0.000322	0.0091	CbGeAlD
Amitriptyline—HTR2A—artery—type 2 diabetes mellitus	0.000293	0.0083	CbGeAlD
Amitriptyline—HTR2A—nerve—type 2 diabetes mellitus	0.000291	0.00824	CbGeAlD
Amitriptyline—ADRA1B—kidney—type 2 diabetes mellitus	0.000275	0.00777	CbGeAlD
Amitriptyline—Aprindine—CALM1—type 2 diabetes mellitus	0.000266	0.108	CrCbGaD
Amitriptyline—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.000265	0.00749	CbGeAlD
Amitriptyline—KCND3—liver—type 2 diabetes mellitus	0.000255	0.00722	CbGeAlD
Amitriptyline—HTR2A—endothelium—type 2 diabetes mellitus	0.000248	0.00701	CbGeAlD
Amitriptyline—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.000213	0.00603	CbGeAlD
Amitriptyline—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000212	0.006	CbGeAlD
Amitriptyline—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000211	0.00597	CbGeAlD
Amitriptyline—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000205	0.00581	CbGeAlD
Amitriptyline—HTR1D—kidney—type 2 diabetes mellitus	0.000201	0.00568	CbGeAlD
Amitriptyline—HRH2—liver—type 2 diabetes mellitus	0.000199	0.00563	CbGeAlD
Amitriptyline—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000192	0.00543	CbGeAlD
Amitriptyline—SIGMAR1—pancreas—type 2 diabetes mellitus	0.000186	0.00526	CbGeAlD
Amitriptyline—DRD2—retina—type 2 diabetes mellitus	0.000183	0.00517	CbGeAlD
Amitriptyline—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.000182	0.00516	CbGeAlD
Amitriptyline—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000174	0.00492	CbGeAlD
Amitriptyline—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000171	0.00484	CbGeAlD
Amitriptyline—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.000169	0.00478	CbGeAlD
Amitriptyline—CHRM3—kidney—type 2 diabetes mellitus	0.000168	0.00476	CbGeAlD
Amitriptyline—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000166	0.00469	CbGeAlD
Amitriptyline—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000164	0.00463	CbGeAlD
Amitriptyline—HTR7—kidney—type 2 diabetes mellitus	0.00016	0.00453	CbGeAlD
Amitriptyline—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000158	0.00446	CbGeAlD
Amitriptyline—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000151	0.00429	CbGeAlD
Amitriptyline—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.00014	0.00396	CbGeAlD
Amitriptyline—ORM1—liver—type 2 diabetes mellitus	0.00014	0.00396	CbGeAlD
Amitriptyline—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000139	0.00394	CbGeAlD
Amitriptyline—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000139	0.00394	CbGeAlD
Amitriptyline—CYP2C8—kidney—type 2 diabetes mellitus	0.000136	0.00386	CbGeAlD
Amitriptyline—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000131	0.0037	CbGeAlD
Amitriptyline—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000125	0.00354	CbGeAlD
Amitriptyline—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000124	0.0035	CbGeAlD
Amitriptyline—CYP3A5—kidney—type 2 diabetes mellitus	0.000123	0.00348	CbGeAlD
Amitriptyline—ALB—liver—type 2 diabetes mellitus	0.000123	0.00347	CbGeAlD
Amitriptyline—CYP2B6—kidney—type 2 diabetes mellitus	0.000122	0.00346	CbGeAlD
Amitriptyline—CYP3A5—pancreas—type 2 diabetes mellitus	0.000122	0.00346	CbGeAlD
Amitriptyline—HTR2A—retina—type 2 diabetes mellitus	0.000121	0.00341	CbGeAlD
Amitriptyline—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.00012	0.00339	CbGeAlD
Amitriptyline—SIGMAR1—liver—type 2 diabetes mellitus	0.000118	0.00335	CbGeAlD
Amitriptyline—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000117	0.00332	CbGeAlD
Amitriptyline—ADRA2A—pancreas—type 2 diabetes mellitus	0.000117	0.0033	CbGeAlD
Amitriptyline—CYP2E1—kidney—type 2 diabetes mellitus	0.000115	0.00325	CbGeAlD
Amitriptyline—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000114	0.00323	CbGeAlD
Amitriptyline—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000112	0.00316	CbGeAlD
Amitriptyline—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000111	0.00314	CbGeAlD
Amitriptyline—HRH1—adipose tissue—type 2 diabetes mellitus	0.000108	0.00305	CbGeAlD
Amitriptyline—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000106	0.00299	CbGeAlD
Amitriptyline—Promethazine—CALM1—type 2 diabetes mellitus	0.000105	0.0426	CrCbGaD
Amitriptyline—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000102	0.00289	CbGeAlD
Amitriptyline—Epinastine—ADRA2A—type 2 diabetes mellitus	0.000102	0.0411	CrCbGaD
Amitriptyline—HTR7—liver—type 2 diabetes mellitus	0.000101	0.00286	CbGeAlD
Amitriptyline—HTR2A—kidney—type 2 diabetes mellitus	9.98e-05	0.00282	CbGeAlD
Amitriptyline—CYP2C19—liver—type 2 diabetes mellitus	9.88e-05	0.00279	CbGeAlD
Amitriptyline—ADRA1A—liver—type 2 diabetes mellitus	9.75e-05	0.00276	CbGeAlD
Amitriptyline—ABCB1—islet of Langerhans—type 2 diabetes mellitus	9.24e-05	0.00261	CbGeAlD
Amitriptyline—CYP3A4—kidney—type 2 diabetes mellitus	9.24e-05	0.00261	CbGeAlD
Amitriptyline—CYP2D6—kidney—type 2 diabetes mellitus	9.09e-05	0.00257	CbGeAlD
Amitriptyline—CYP2C8—liver—type 2 diabetes mellitus	8.62e-05	0.00244	CbGeAlD
Amitriptyline—Dry mouth—Orlistat—type 2 diabetes mellitus	8.24e-05	0.000845	CcSEcCtD
Amitriptyline—Malaise—Metformin—type 2 diabetes mellitus	8.23e-05	0.000843	CcSEcCtD
Amitriptyline—Alopecia—Losartan—type 2 diabetes mellitus	8.23e-05	0.000843	CcSEcCtD
Amitriptyline—Diarrhoea—Glimepiride—type 2 diabetes mellitus	8.22e-05	0.000843	CcSEcCtD
Amitriptyline—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	8.2e-05	0.00084	CcSEcCtD
Amitriptyline—Vomiting—Glipizide—type 2 diabetes mellitus	8.19e-05	0.000839	CcSEcCtD
Amitriptyline—Syncope—Metformin—type 2 diabetes mellitus	8.18e-05	0.000838	CcSEcCtD
Amitriptyline—Oedema—Valsartan—type 2 diabetes mellitus	8.18e-05	0.000838	CcSEcCtD
Amitriptyline—Feeling abnormal—Glyburide—type 2 diabetes mellitus	8.17e-05	0.000837	CcSEcCtD
Amitriptyline—Dizziness—Pioglitazone—type 2 diabetes mellitus	8.16e-05	0.000836	CcSEcCtD
Amitriptyline—Rash—Glipizide—type 2 diabetes mellitus	8.12e-05	0.000832	CcSEcCtD
Amitriptyline—Vision blurred—Irbesartan—type 2 diabetes mellitus	8.12e-05	0.000832	CcSEcCtD
Amitriptyline—Dermatitis—Glipizide—type 2 diabetes mellitus	8.11e-05	0.000831	CcSEcCtD
Amitriptyline—Oedema—Orlistat—type 2 diabetes mellitus	8.08e-05	0.000828	CcSEcCtD
Amitriptyline—Azatadine—CYP3A4—type 2 diabetes mellitus	8.08e-05	0.0327	CrCbGaD
Amitriptyline—Headache—Glipizide—type 2 diabetes mellitus	8.07e-05	0.000827	CcSEcCtD
Amitriptyline—Tremor—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.000827	CcSEcCtD
Amitriptyline—CYP1A2—liver—type 2 diabetes mellitus	8.07e-05	0.00228	CbGeAlD
Amitriptyline—Palpitations—Metformin—type 2 diabetes mellitus	8.06e-05	0.000826	CcSEcCtD
Amitriptyline—Insomnia—Gliclazide—type 2 diabetes mellitus	8.05e-05	0.000825	CcSEcCtD
Amitriptyline—Shock—Valsartan—type 2 diabetes mellitus	8.05e-05	0.000824	CcSEcCtD
Amitriptyline—Loss of consciousness—Metformin—type 2 diabetes mellitus	8.02e-05	0.000822	CcSEcCtD
Amitriptyline—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	8.01e-05	0.00082	CcSEcCtD
Amitriptyline—Paraesthesia—Gliclazide—type 2 diabetes mellitus	7.99e-05	0.000819	CcSEcCtD
Amitriptyline—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	7.99e-05	0.000819	CcSEcCtD
Amitriptyline—Hepatitis—Ramipril—type 2 diabetes mellitus	7.98e-05	0.000818	CcSEcCtD
Amitriptyline—Dizziness—Glimepiride—type 2 diabetes mellitus	7.95e-05	0.000814	CcSEcCtD
Amitriptyline—Dysgeusia—Losartan—type 2 diabetes mellitus	7.94e-05	0.000813	CcSEcCtD
Amitriptyline—Dizziness—Sitagliptin—type 2 diabetes mellitus	7.92e-05	0.000812	CcSEcCtD
Amitriptyline—Agitation—Irbesartan—type 2 diabetes mellitus	7.91e-05	0.000811	CcSEcCtD
Amitriptyline—Somnolence—Gliclazide—type 2 diabetes mellitus	7.91e-05	0.000811	CcSEcCtD
Amitriptyline—ABCB1—retina—type 2 diabetes mellitus	7.9e-05	0.00224	CbGeAlD
Amitriptyline—Hypertension—Metformin—type 2 diabetes mellitus	7.88e-05	0.000807	CcSEcCtD
Amitriptyline—Urticaria—Glyburide—type 2 diabetes mellitus	7.88e-05	0.000807	CcSEcCtD
Amitriptyline—Dyspepsia—Gliclazide—type 2 diabetes mellitus	7.84e-05	0.000803	CcSEcCtD
Amitriptyline—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	7.81e-05	0.0008	CcSEcCtD
Amitriptyline—Anorexia—Valsartan—type 2 diabetes mellitus	7.8e-05	0.000799	CcSEcCtD
Amitriptyline—Asthenia—Bromocriptine—type 2 diabetes mellitus	7.78e-05	0.000797	CcSEcCtD
Amitriptyline—CYP3A5—liver—type 2 diabetes mellitus	7.78e-05	0.0022	CbGeAlD
Amitriptyline—Malaise—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000796	CcSEcCtD
Amitriptyline—CYP2B6—liver—type 2 diabetes mellitus	7.73e-05	0.00219	CbGeAlD
Amitriptyline—Headache—Pioglitazone—type 2 diabetes mellitus	7.73e-05	0.000792	CcSEcCtD
Amitriptyline—Syncope—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000791	CcSEcCtD
Amitriptyline—Leukopenia—Irbesartan—type 2 diabetes mellitus	7.71e-05	0.00079	CcSEcCtD
Amitriptyline—Discomfort—Metformin—type 2 diabetes mellitus	7.68e-05	0.000786	CcSEcCtD
Amitriptyline—Fatigue—Gliclazide—type 2 diabetes mellitus	7.67e-05	0.000786	CcSEcCtD
Amitriptyline—CYP2C9—liver—type 2 diabetes mellitus	7.66e-05	0.00217	CbGeAlD
Amitriptyline—Nausea—Glipizide—type 2 diabetes mellitus	7.65e-05	0.000784	CcSEcCtD
Amitriptyline—Vomiting—Glimepiride—type 2 diabetes mellitus	7.64e-05	0.000783	CcSEcCtD
Amitriptyline—Hypotension—Valsartan—type 2 diabetes mellitus	7.64e-05	0.000783	CcSEcCtD
Amitriptyline—Vision blurred—Losartan—type 2 diabetes mellitus	7.64e-05	0.000783	CcSEcCtD
Amitriptyline—Vomiting—Sitagliptin—type 2 diabetes mellitus	7.62e-05	0.000781	CcSEcCtD
Amitriptyline—Constipation—Gliclazide—type 2 diabetes mellitus	7.61e-05	0.00078	CcSEcCtD
Amitriptyline—Tremor—Losartan—type 2 diabetes mellitus	7.59e-05	0.000778	CcSEcCtD
Amitriptyline—Rash—Glimepiride—type 2 diabetes mellitus	7.58e-05	0.000777	CcSEcCtD
Amitriptyline—Dermatitis—Glimepiride—type 2 diabetes mellitus	7.57e-05	0.000776	CcSEcCtD
Amitriptyline—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000776	CcSEcCtD
Amitriptyline—Rash—Sitagliptin—type 2 diabetes mellitus	7.56e-05	0.000774	CcSEcCtD
Amitriptyline—Dermatitis—Sitagliptin—type 2 diabetes mellitus	7.55e-05	0.000773	CcSEcCtD
Amitriptyline—Headache—Glimepiride—type 2 diabetes mellitus	7.53e-05	0.000772	CcSEcCtD
Amitriptyline—Ill-defined disorder—Losartan—type 2 diabetes mellitus	7.52e-05	0.00077	CcSEcCtD
Amitriptyline—Headache—Sitagliptin—type 2 diabetes mellitus	7.51e-05	0.000769	CcSEcCtD
Amitriptyline—Agitation—Losartan—type 2 diabetes mellitus	7.45e-05	0.000763	CcSEcCtD
Amitriptyline—Oedema—Metformin—type 2 diabetes mellitus	7.45e-05	0.000763	CcSEcCtD
Amitriptyline—Tinnitus—Ramipril—type 2 diabetes mellitus	7.44e-05	0.000763	CcSEcCtD
Amitriptyline—ABCB1—nephron tubule—type 2 diabetes mellitus	7.44e-05	0.00211	CbGeAlD
Amitriptyline—Hypertension—Irbesartan—type 2 diabetes mellitus	7.44e-05	0.000762	CcSEcCtD
Amitriptyline—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.42e-05	0.00076	CcSEcCtD
Amitriptyline—Insomnia—Valsartan—type 2 diabetes mellitus	7.4e-05	0.000758	CcSEcCtD
Amitriptyline—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.34e-05	0.000752	CcSEcCtD
Amitriptyline—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.34e-05	0.000752	CcSEcCtD
Amitriptyline—Shock—Metformin—type 2 diabetes mellitus	7.33e-05	0.000751	CcSEcCtD
Amitriptyline—Insomnia—Orlistat—type 2 diabetes mellitus	7.31e-05	0.000749	CcSEcCtD
Amitriptyline—Malaise—Losartan—type 2 diabetes mellitus	7.31e-05	0.000749	CcSEcCtD
Amitriptyline—Anxiety—Irbesartan—type 2 diabetes mellitus	7.31e-05	0.000749	CcSEcCtD
Amitriptyline—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.29e-05	0.000747	CcSEcCtD
Amitriptyline—Somnolence—Valsartan—type 2 diabetes mellitus	7.27e-05	0.000745	CcSEcCtD
Amitriptyline—Syncope—Losartan—type 2 diabetes mellitus	7.27e-05	0.000745	CcSEcCtD
Amitriptyline—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.26e-05	0.000744	CcSEcCtD
Amitriptyline—CYP2E1—liver—type 2 diabetes mellitus	7.26e-05	0.00205	CbGeAlD
Amitriptyline—Leukopenia—Losartan—type 2 diabetes mellitus	7.25e-05	0.000743	CcSEcCtD
Amitriptyline—Discomfort—Irbesartan—type 2 diabetes mellitus	7.24e-05	0.000742	CcSEcCtD
Amitriptyline—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.2e-05	0.000738	CcSEcCtD
Amitriptyline—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.2e-05	0.000738	CcSEcCtD
Amitriptyline—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.17e-05	0.000735	CcSEcCtD
Amitriptyline—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.17e-05	0.000735	CcSEcCtD
Amitriptyline—Palpitations—Losartan—type 2 diabetes mellitus	7.16e-05	0.000734	CcSEcCtD
Amitriptyline—Cyproheptadine—HTR2C—type 2 diabetes mellitus	7.14e-05	0.0289	CrCbGaD
Amitriptyline—Nausea—Glimepiride—type 2 diabetes mellitus	7.14e-05	0.000732	CcSEcCtD
Amitriptyline—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.13e-05	0.000731	CcSEcCtD
Amitriptyline—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.12e-05	0.00073	CcSEcCtD
Amitriptyline—Nausea—Sitagliptin—type 2 diabetes mellitus	7.12e-05	0.000729	CcSEcCtD
Amitriptyline—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.11e-05	0.000729	CcSEcCtD
Amitriptyline—Asthenia—Glyburide—type 2 diabetes mellitus	7.11e-05	0.000729	CcSEcCtD
Amitriptyline—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	7.11e-05	0.0288	CrCbGaD
Amitriptyline—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.11e-05	0.000728	CcSEcCtD
Amitriptyline—Anorexia—Metformin—type 2 diabetes mellitus	7.1e-05	0.000727	CcSEcCtD
Amitriptyline—Urticaria—Gliclazide—type 2 diabetes mellitus	7.07e-05	0.000725	CcSEcCtD
Amitriptyline—Alopecia—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000723	CcSEcCtD
Amitriptyline—Fatigue—Valsartan—type 2 diabetes mellitus	7.05e-05	0.000722	CcSEcCtD
Amitriptyline—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.04e-05	0.000721	CcSEcCtD
Amitriptyline—Oedema—Irbesartan—type 2 diabetes mellitus	7.03e-05	0.00072	CcSEcCtD
Amitriptyline—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.03e-05	0.00072	CcSEcCtD
Amitriptyline—Pruritus—Glyburide—type 2 diabetes mellitus	7.01e-05	0.000719	CcSEcCtD
Amitriptyline—Constipation—Valsartan—type 2 diabetes mellitus	6.99e-05	0.000717	CcSEcCtD
Amitriptyline—Fatigue—Orlistat—type 2 diabetes mellitus	6.97e-05	0.000714	CcSEcCtD
Amitriptyline—Hypotension—Metformin—type 2 diabetes mellitus	6.96e-05	0.000713	CcSEcCtD
Amitriptyline—Shock—Irbesartan—type 2 diabetes mellitus	6.91e-05	0.000709	CcSEcCtD
Amitriptyline—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.89e-05	0.000706	CcSEcCtD
Amitriptyline—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6.88e-05	0.000705	CcSEcCtD
Amitriptyline—Anxiety—Losartan—type 2 diabetes mellitus	6.88e-05	0.000705	CcSEcCtD
Amitriptyline—Tachycardia—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.000703	CcSEcCtD
Amitriptyline—Rash—Bromocriptine—type 2 diabetes mellitus	6.84e-05	0.000701	CcSEcCtD
Amitriptyline—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.83e-05	0.0007	CcSEcCtD
Amitriptyline—Discomfort—Losartan—type 2 diabetes mellitus	6.82e-05	0.000698	CcSEcCtD
Amitriptyline—Dysgeusia—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000697	CcSEcCtD
Amitriptyline—Thiothixene—ADRA2A—type 2 diabetes mellitus	6.8e-05	0.0275	CrCbGaD
Amitriptyline—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.79e-05	0.000696	CcSEcCtD
Amitriptyline—Headache—Bromocriptine—type 2 diabetes mellitus	6.79e-05	0.000696	CcSEcCtD
Amitriptyline—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.78e-05	0.000695	CcSEcCtD
Amitriptyline—Dry mouth—Losartan—type 2 diabetes mellitus	6.75e-05	0.000691	CcSEcCtD
Amitriptyline—Anorexia—Irbesartan—type 2 diabetes mellitus	6.7e-05	0.000686	CcSEcCtD
Amitriptyline—Paraesthesia—Metformin—type 2 diabetes mellitus	6.69e-05	0.000685	CcSEcCtD
Amitriptyline—ABCB1—cardiovascular system—type 2 diabetes mellitus	6.68e-05	0.00189	CbGeAlD
Amitriptyline—Confusional state—Losartan—type 2 diabetes mellitus	6.67e-05	0.000683	CcSEcCtD
Amitriptyline—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.66e-05	0.000682	CcSEcCtD
Amitriptyline—Somnolence—Metformin—type 2 diabetes mellitus	6.62e-05	0.000678	CcSEcCtD
Amitriptyline—Oedema—Losartan—type 2 diabetes mellitus	6.61e-05	0.000678	CcSEcCtD
Amitriptyline—Hypotension—Irbesartan—type 2 diabetes mellitus	6.57e-05	0.000673	CcSEcCtD
Amitriptyline—Dyspepsia—Metformin—type 2 diabetes mellitus	6.56e-05	0.000672	CcSEcCtD
Amitriptyline—ABCB1—kidney—type 2 diabetes mellitus	6.54e-05	0.00185	CbGeAlD
Amitriptyline—Tremor—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000667	CcSEcCtD
Amitriptyline—Shock—Losartan—type 2 diabetes mellitus	6.51e-05	0.000667	CcSEcCtD
Amitriptyline—Urticaria—Valsartan—type 2 diabetes mellitus	6.5e-05	0.000666	CcSEcCtD
Amitriptyline—ABCB1—pancreas—type 2 diabetes mellitus	6.49e-05	0.00184	CbGeAlD
Amitriptyline—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.48e-05	0.000664	CcSEcCtD
Amitriptyline—Decreased appetite—Metformin—type 2 diabetes mellitus	6.47e-05	0.000663	CcSEcCtD
Amitriptyline—Tachycardia—Losartan—type 2 diabetes mellitus	6.46e-05	0.000661	CcSEcCtD
Amitriptyline—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000661	CcSEcCtD
Amitriptyline—Nausea—Bromocriptine—type 2 diabetes mellitus	6.44e-05	0.00066	CcSEcCtD
Amitriptyline—Fatigue—Metformin—type 2 diabetes mellitus	6.42e-05	0.000658	CcSEcCtD
Amitriptyline—Urticaria—Orlistat—type 2 diabetes mellitus	6.42e-05	0.000658	CcSEcCtD
Amitriptyline—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.39e-05	0.000655	CcSEcCtD
Amitriptyline—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.39e-05	0.000655	CcSEcCtD
Amitriptyline—Asthenia—Gliclazide—type 2 diabetes mellitus	6.39e-05	0.000654	CcSEcCtD
Amitriptyline—Agitation—Ramipril—type 2 diabetes mellitus	6.39e-05	0.000654	CcSEcCtD
Amitriptyline—Constipation—Metformin—type 2 diabetes mellitus	6.37e-05	0.000653	CcSEcCtD
Amitriptyline—ABCB1—cortex of kidney—type 2 diabetes mellitus	6.37e-05	0.0018	CbGeAlD
Amitriptyline—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.31e-05	0.000647	CcSEcCtD
Amitriptyline—HTR2A—liver—type 2 diabetes mellitus	6.31e-05	0.00178	CbGeAlD
Amitriptyline—Anorexia—Losartan—type 2 diabetes mellitus	6.3e-05	0.000646	CcSEcCtD
Amitriptyline—Vomiting—Glyburide—type 2 diabetes mellitus	6.3e-05	0.000646	CcSEcCtD
Amitriptyline—Pruritus—Gliclazide—type 2 diabetes mellitus	6.3e-05	0.000645	CcSEcCtD
Amitriptyline—Malaise—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000642	CcSEcCtD
Amitriptyline—Thiothixene—HTR2C—type 2 diabetes mellitus	6.26e-05	0.0253	CrCbGaD
Amitriptyline—Rash—Glyburide—type 2 diabetes mellitus	6.25e-05	0.00064	CcSEcCtD
Amitriptyline—Somnolence—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.00064	CcSEcCtD
Amitriptyline—Dermatitis—Glyburide—type 2 diabetes mellitus	6.24e-05	0.00064	CcSEcCtD
Amitriptyline—Syncope—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000639	CcSEcCtD
Amitriptyline—Leukopenia—Ramipril—type 2 diabetes mellitus	6.22e-05	0.000637	CcSEcCtD
Amitriptyline—Headache—Glyburide—type 2 diabetes mellitus	6.21e-05	0.000636	CcSEcCtD
Amitriptyline—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000634	CcSEcCtD
Amitriptyline—Hypotension—Losartan—type 2 diabetes mellitus	6.18e-05	0.000633	CcSEcCtD
Amitriptyline—Palpitations—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000629	CcSEcCtD
Amitriptyline—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.14e-05	0.000629	CcSEcCtD
Amitriptyline—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.11e-05	0.000626	CcSEcCtD
Amitriptyline—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000626	CcSEcCtD
Amitriptyline—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.09e-05	0.000624	CcSEcCtD
Amitriptyline—Fatigue—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000621	CcSEcCtD
Amitriptyline—Convulsion—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000617	CcSEcCtD
Amitriptyline—Constipation—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000616	CcSEcCtD
Amitriptyline—Insomnia—Losartan—type 2 diabetes mellitus	5.98e-05	0.000613	CcSEcCtD
Amitriptyline—Paraesthesia—Losartan—type 2 diabetes mellitus	5.94e-05	0.000609	CcSEcCtD
Amitriptyline—Urticaria—Metformin—type 2 diabetes mellitus	5.92e-05	0.000606	CcSEcCtD
Amitriptyline—Anxiety—Ramipril—type 2 diabetes mellitus	5.9e-05	0.000604	CcSEcCtD
Amitriptyline—ABCB1—adipose tissue—type 2 diabetes mellitus	5.89e-05	0.00167	CbGeAlD
Amitriptyline—Nausea—Glyburide—type 2 diabetes mellitus	5.89e-05	0.000603	CcSEcCtD
Amitriptyline—Dizziness—Gliclazide—type 2 diabetes mellitus	5.89e-05	0.000603	CcSEcCtD
Amitriptyline—Somnolence—Losartan—type 2 diabetes mellitus	5.88e-05	0.000602	CcSEcCtD
Amitriptyline—Mianserin—ADRA2A—type 2 diabetes mellitus	5.88e-05	0.0238	CrCbGaD
Amitriptyline—Asthenia—Valsartan—type 2 diabetes mellitus	5.87e-05	0.000601	CcSEcCtD
Amitriptyline—Discomfort—Ramipril—type 2 diabetes mellitus	5.85e-05	0.000599	CcSEcCtD
Amitriptyline—CYP3A4—liver—type 2 diabetes mellitus	5.84e-05	0.00165	CbGeAlD
Amitriptyline—Dyspepsia—Losartan—type 2 diabetes mellitus	5.82e-05	0.000597	CcSEcCtD
Amitriptyline—Asthenia—Orlistat—type 2 diabetes mellitus	5.8e-05	0.000594	CcSEcCtD
Amitriptyline—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.79e-05	0.000593	CcSEcCtD
Amitriptyline—Pruritus—Valsartan—type 2 diabetes mellitus	5.79e-05	0.000593	CcSEcCtD
Amitriptyline—Dry mouth—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000593	CcSEcCtD
Amitriptyline—Decreased appetite—Losartan—type 2 diabetes mellitus	5.75e-05	0.000589	CcSEcCtD
Amitriptyline—CYP2D6—liver—type 2 diabetes mellitus	5.74e-05	0.00163	CbGeAlD
Amitriptyline—Confusional state—Ramipril—type 2 diabetes mellitus	5.72e-05	0.000586	CcSEcCtD
Amitriptyline—Pruritus—Orlistat—type 2 diabetes mellitus	5.72e-05	0.000586	CcSEcCtD
Amitriptyline—Fatigue—Losartan—type 2 diabetes mellitus	5.7e-05	0.000584	CcSEcCtD
Amitriptyline—Oedema—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000581	CcSEcCtD
Amitriptyline—Vomiting—Gliclazide—type 2 diabetes mellitus	5.66e-05	0.00058	CcSEcCtD
Amitriptyline—Constipation—Losartan—type 2 diabetes mellitus	5.66e-05	0.00058	CcSEcCtD
Amitriptyline—Rash—Gliclazide—type 2 diabetes mellitus	5.61e-05	0.000575	CcSEcCtD
Amitriptyline—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.61e-05	0.000575	CcSEcCtD
Amitriptyline—Olopatadine—CYP3A4—type 2 diabetes mellitus	5.6e-05	0.0226	CrCbGaD
Amitriptyline—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.6e-05	0.000573	CcSEcCtD
Amitriptyline—Urticaria—Irbesartan—type 2 diabetes mellitus	5.58e-05	0.000572	CcSEcCtD
Amitriptyline—Shock—Ramipril—type 2 diabetes mellitus	5.58e-05	0.000572	CcSEcCtD
Amitriptyline—Headache—Gliclazide—type 2 diabetes mellitus	5.58e-05	0.000571	CcSEcCtD
Amitriptyline—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.56e-05	0.000569	CcSEcCtD
Amitriptyline—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000569	CcSEcCtD
Amitriptyline—Tachycardia—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000567	CcSEcCtD
Amitriptyline—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.53e-05	0.000567	CcSEcCtD
Amitriptyline—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.48e-05	0.000562	CcSEcCtD
Amitriptyline—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.45e-05	0.000558	CcSEcCtD
Amitriptyline—Mianserin—HTR2C—type 2 diabetes mellitus	5.41e-05	0.0219	CrCbGaD
Amitriptyline—Dizziness—Valsartan—type 2 diabetes mellitus	5.41e-05	0.000554	CcSEcCtD
Amitriptyline—Anorexia—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000554	CcSEcCtD
Amitriptyline—Clomipramine—ADRA2A—type 2 diabetes mellitus	5.38e-05	0.0217	CrCbGaD
Amitriptyline—Dizziness—Orlistat—type 2 diabetes mellitus	5.34e-05	0.000548	CcSEcCtD
Amitriptyline—Asthenia—Metformin—type 2 diabetes mellitus	5.34e-05	0.000548	CcSEcCtD
Amitriptyline—Hypotension—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000543	CcSEcCtD
Amitriptyline—Nausea—Gliclazide—type 2 diabetes mellitus	5.29e-05	0.000542	CcSEcCtD
Amitriptyline—Pruritus—Metformin—type 2 diabetes mellitus	5.27e-05	0.00054	CcSEcCtD
Amitriptyline—Urticaria—Losartan—type 2 diabetes mellitus	5.25e-05	0.000538	CcSEcCtD
Amitriptyline—Body temperature increased—Losartan—type 2 diabetes mellitus	5.23e-05	0.000536	CcSEcCtD
Amitriptyline—Vomiting—Valsartan—type 2 diabetes mellitus	5.2e-05	0.000533	CcSEcCtD
Amitriptyline—Rash—Valsartan—type 2 diabetes mellitus	5.16e-05	0.000528	CcSEcCtD
Amitriptyline—Dermatitis—Valsartan—type 2 diabetes mellitus	5.15e-05	0.000528	CcSEcCtD
Amitriptyline—Vomiting—Orlistat—type 2 diabetes mellitus	5.14e-05	0.000526	CcSEcCtD
Amitriptyline—Insomnia—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000526	CcSEcCtD
Amitriptyline—Headache—Valsartan—type 2 diabetes mellitus	5.12e-05	0.000525	CcSEcCtD
Amitriptyline—Alimemazine—CYP3A4—type 2 diabetes mellitus	5.11e-05	0.0207	CrCbGaD
Amitriptyline—Diarrhoea—Metformin—type 2 diabetes mellitus	5.1e-05	0.000522	CcSEcCtD
Amitriptyline—Rash—Orlistat—type 2 diabetes mellitus	5.1e-05	0.000522	CcSEcCtD
Amitriptyline—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000522	CcSEcCtD
Amitriptyline—Dermatitis—Orlistat—type 2 diabetes mellitus	5.09e-05	0.000522	CcSEcCtD
Amitriptyline—Headache—Orlistat—type 2 diabetes mellitus	5.06e-05	0.000519	CcSEcCtD
Amitriptyline—Asthenia—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.000517	CcSEcCtD
Amitriptyline—Somnolence—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000517	CcSEcCtD
Amitriptyline—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000512	CcSEcCtD
Amitriptyline—Pruritus—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.000509	CcSEcCtD
Amitriptyline—Clomipramine—HTR2C—type 2 diabetes mellitus	4.95e-05	0.02	CrCbGaD
Amitriptyline—Trimipramine—ADRA2A—type 2 diabetes mellitus	4.95e-05	0.02	CrCbGaD
Amitriptyline—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.93e-05	0.000505	CcSEcCtD
Amitriptyline—Chlorprothixene—HTR2C—type 2 diabetes mellitus	4.93e-05	0.0199	CrCbGaD
Amitriptyline—Dizziness—Metformin—type 2 diabetes mellitus	4.92e-05	0.000505	CcSEcCtD
Amitriptyline—Fatigue—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000501	CcSEcCtD
Amitriptyline—Nausea—Valsartan—type 2 diabetes mellitus	4.86e-05	0.000498	CcSEcCtD
Amitriptyline—Constipation—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000497	CcSEcCtD
Amitriptyline—Nortriptyline—HTR2C—type 2 diabetes mellitus	4.84e-05	0.0196	CrCbGaD
Amitriptyline—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.81e-05	0.000493	CcSEcCtD
Amitriptyline—Nausea—Orlistat—type 2 diabetes mellitus	4.8e-05	0.000492	CcSEcCtD
Amitriptyline—Asthenia—Losartan—type 2 diabetes mellitus	4.75e-05	0.000486	CcSEcCtD
Amitriptyline—Vomiting—Metformin—type 2 diabetes mellitus	4.74e-05	0.000485	CcSEcCtD
Amitriptyline—Thiothixene—CYP1A2—type 2 diabetes mellitus	4.73e-05	0.0191	CrCbGaD
Amitriptyline—Doxepin—ADRA2A—type 2 diabetes mellitus	4.72e-05	0.0191	CrCbGaD
Amitriptyline—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	4.71e-05	0.019	CrCbGaD
Amitriptyline—Rash—Metformin—type 2 diabetes mellitus	4.7e-05	0.000481	CcSEcCtD
Amitriptyline—Dermatitis—Metformin—type 2 diabetes mellitus	4.69e-05	0.000481	CcSEcCtD
Amitriptyline—Pruritus—Losartan—type 2 diabetes mellitus	4.68e-05	0.000479	CcSEcCtD
Amitriptyline—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000479	CcSEcCtD
Amitriptyline—Epinastine—CYP3A4—type 2 diabetes mellitus	4.67e-05	0.0189	CrCbGaD
Amitriptyline—Headache—Metformin—type 2 diabetes mellitus	4.67e-05	0.000478	CcSEcCtD
Amitriptyline—Dizziness—Irbesartan—type 2 diabetes mellitus	4.65e-05	0.000476	CcSEcCtD
Amitriptyline—Trimipramine—HTR2C—type 2 diabetes mellitus	4.55e-05	0.0184	CrCbGaD
Amitriptyline—Diarrhoea—Losartan—type 2 diabetes mellitus	4.53e-05	0.000464	CcSEcCtD
Amitriptyline—Urticaria—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000462	CcSEcCtD
Amitriptyline—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.48e-05	0.000459	CcSEcCtD
Amitriptyline—Vomiting—Irbesartan—type 2 diabetes mellitus	4.47e-05	0.000458	CcSEcCtD
Amitriptyline—Rash—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000454	CcSEcCtD
Amitriptyline—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000454	CcSEcCtD
Amitriptyline—Nausea—Metformin—type 2 diabetes mellitus	4.42e-05	0.000453	CcSEcCtD
Amitriptyline—Headache—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000451	CcSEcCtD
Amitriptyline—Dizziness—Losartan—type 2 diabetes mellitus	4.37e-05	0.000448	CcSEcCtD
Amitriptyline—Doxepin—HTR2C—type 2 diabetes mellitus	4.34e-05	0.0176	CrCbGaD
Amitriptyline—Oxcarbazepine—CYP3A4—type 2 diabetes mellitus	4.31e-05	0.0174	CrCbGaD
Amitriptyline—Vomiting—Losartan—type 2 diabetes mellitus	4.21e-05	0.000431	CcSEcCtD
Amitriptyline—Promazine—ADRA2A—type 2 diabetes mellitus	4.19e-05	0.0169	CrCbGaD
Amitriptyline—Nausea—Irbesartan—type 2 diabetes mellitus	4.17e-05	0.000428	CcSEcCtD
Amitriptyline—Rash—Losartan—type 2 diabetes mellitus	4.17e-05	0.000427	CcSEcCtD
Amitriptyline—Dermatitis—Losartan—type 2 diabetes mellitus	4.17e-05	0.000427	CcSEcCtD
Amitriptyline—Headache—Losartan—type 2 diabetes mellitus	4.14e-05	0.000425	CcSEcCtD
Amitriptyline—ABCB1—liver—type 2 diabetes mellitus	4.13e-05	0.00117	CbGeAlD
Amitriptyline—Mianserin—CYP1A2—type 2 diabetes mellitus	4.08e-05	0.0165	CrCbGaD
Amitriptyline—Asthenia—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000417	CcSEcCtD
Amitriptyline—Pruritus—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000411	CcSEcCtD
Amitriptyline—Desipramine—HTR2C—type 2 diabetes mellitus	3.98e-05	0.0161	CrCbGaD
Amitriptyline—Nausea—Losartan—type 2 diabetes mellitus	3.93e-05	0.000403	CcSEcCtD
Amitriptyline—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000398	CcSEcCtD
Amitriptyline—Promazine—HTR2C—type 2 diabetes mellitus	3.86e-05	0.0156	CrCbGaD
Amitriptyline—Nortriptyline—CYP2E1—type 2 diabetes mellitus	3.84e-05	0.0155	CrCbGaD
Amitriptyline—Oxcarbazepine—ALB—type 2 diabetes mellitus	3.76e-05	0.0152	CrCbGaD
Amitriptyline—Dizziness—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000384	CcSEcCtD
Amitriptyline—Clomipramine—CYP1A2—type 2 diabetes mellitus	3.74e-05	0.0151	CrCbGaD
Amitriptyline—Nortriptyline—CYP1A2—type 2 diabetes mellitus	3.65e-05	0.0148	CrCbGaD
Amitriptyline—Vomiting—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000369	CcSEcCtD
Amitriptyline—Rash—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000366	CcSEcCtD
Amitriptyline—Dermatitis—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000366	CcSEcCtD
Amitriptyline—Headache—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000364	CcSEcCtD
Amitriptyline—Imipramine—HTR2C—type 2 diabetes mellitus	3.38e-05	0.0137	CrCbGaD
Amitriptyline—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	3.37e-05	0.0136	CrCbGaD
Amitriptyline—Nausea—Ramipril—type 2 diabetes mellitus	3.37e-05	0.000345	CcSEcCtD
Amitriptyline—Orphenadrine—CYP2E1—type 2 diabetes mellitus	3.36e-05	0.0136	CrCbGaD
Amitriptyline—Doxepin—CYP1A2—type 2 diabetes mellitus	3.28e-05	0.0132	CrCbGaD
Amitriptyline—Desipramine—CYP2E1—type 2 diabetes mellitus	3.16e-05	0.0128	CrCbGaD
Amitriptyline—Desipramine—CYP1A2—type 2 diabetes mellitus	3.01e-05	0.0122	CrCbGaD
Amitriptyline—Promazine—CYP1A2—type 2 diabetes mellitus	2.91e-05	0.0118	CrCbGaD
Amitriptyline—Thiothixene—ALB—type 2 diabetes mellitus	2.73e-05	0.011	CrCbGaD
Amitriptyline—Mianserin—CYP3A4—type 2 diabetes mellitus	2.7e-05	0.0109	CrCbGaD
Amitriptyline—Imipramine—CYP2E1—type 2 diabetes mellitus	2.68e-05	0.0108	CrCbGaD
Amitriptyline—Imipramine—CYP1A2—type 2 diabetes mellitus	2.55e-05	0.0103	CrCbGaD
Amitriptyline—Clomipramine—CYP3A4—type 2 diabetes mellitus	2.47e-05	0.01	CrCbGaD
Amitriptyline—Nortriptyline—CYP3A4—type 2 diabetes mellitus	2.42e-05	0.00977	CrCbGaD
Amitriptyline—Trimipramine—CYP3A4—type 2 diabetes mellitus	2.28e-05	0.0092	CrCbGaD
Amitriptyline—Doxepin—CYP3A4—type 2 diabetes mellitus	2.17e-05	0.00877	CrCbGaD
Amitriptyline—Clomipramine—ALB—type 2 diabetes mellitus	2.16e-05	0.00872	CrCbGaD
Amitriptyline—Orphenadrine—CYP3A4—type 2 diabetes mellitus	2.11e-05	0.00855	CrCbGaD
Amitriptyline—Nortriptyline—ALB—type 2 diabetes mellitus	2.11e-05	0.00852	CrCbGaD
Amitriptyline—Desipramine—CYP3A4—type 2 diabetes mellitus	1.99e-05	0.00805	CrCbGaD
Amitriptyline—Promazine—CYP3A4—type 2 diabetes mellitus	1.93e-05	0.00779	CrCbGaD
Amitriptyline—Imipramine—CYP3A4—type 2 diabetes mellitus	1.69e-05	0.00682	CrCbGaD
Amitriptyline—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	6.46e-07	7.14e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.45e-07	7.14e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.45e-07	7.14e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	6.45e-07	7.14e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.44e-07	7.13e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	6.43e-07	7.12e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	6.43e-07	7.12e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	6.43e-07	7.12e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.41e-07	7.09e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.4e-07	7.09e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.39e-07	7.08e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	6.37e-07	7.05e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.37e-07	7.05e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	6.35e-07	7.03e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.33e-07	7.01e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.31e-07	6.99e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.3e-07	6.97e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	6.3e-07	6.97e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	6.29e-07	6.96e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.27e-07	6.94e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.27e-07	6.94e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	6.27e-07	6.93e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	6.22e-07	6.89e-06	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.22e-07	6.88e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.21e-07	6.87e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	6.19e-07	6.85e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	6.18e-07	6.84e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.18e-07	6.84e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.11e-07	6.77e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.1e-07	6.75e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	6.06e-07	6.71e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.05e-07	6.7e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.05e-07	6.7e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.03e-07	6.68e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	6.03e-07	6.67e-06	CbGpPWpGaD
Amitriptyline—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6e-07	6.64e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.99e-07	6.63e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	5.95e-07	6.59e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	5.95e-07	6.59e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.95e-07	6.58e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	5.94e-07	6.57e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.94e-07	6.57e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.94e-07	6.57e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	5.92e-07	6.55e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—NOS3—type 2 diabetes mellitus	5.92e-07	6.55e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—INS—type 2 diabetes mellitus	5.91e-07	6.55e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.91e-07	6.54e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.91e-07	6.54e-06	CbGpPWpGaD
Amitriptyline—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.91e-07	6.54e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.9e-07	6.53e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.9e-07	6.53e-06	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.9e-07	6.52e-06	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.88e-07	6.5e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	5.87e-07	6.5e-06	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.86e-07	6.48e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.85e-07	6.48e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.84e-07	6.46e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	5.82e-07	6.45e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.82e-07	6.44e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.82e-07	6.44e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.8e-07	6.42e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.8e-07	6.42e-06	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.8e-07	6.42e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.78e-07	6.4e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.78e-07	6.4e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.77e-07	6.38e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.75e-07	6.36e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.75e-07	6.36e-06	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.73e-07	6.35e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.73e-07	6.34e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.72e-07	6.33e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.71e-07	6.32e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.69e-07	6.3e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	5.68e-07	6.29e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	5.64e-07	6.24e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.63e-07	6.23e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	5.62e-07	6.22e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.62e-07	6.22e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.59e-07	6.19e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.59e-07	6.19e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	5.57e-07	6.17e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.56e-07	6.16e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.56e-07	6.15e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	5.56e-07	6.15e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	5.55e-07	6.14e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.53e-07	6.12e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	5.53e-07	6.12e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.53e-07	6.11e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.52e-07	6.11e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.5e-07	6.09e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.49e-07	6.08e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.48e-07	6.07e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.48e-07	6.06e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.47e-07	6.06e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	5.46e-07	6.05e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.46e-07	6.04e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.45e-07	6.03e-06	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.45e-07	6.03e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	5.45e-07	6.03e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.44e-07	6.02e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.43e-07	6.01e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.43e-07	6e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	5.42e-07	6e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.42e-07	5.99e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	5.41e-07	5.99e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.37e-07	5.95e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.37e-07	5.95e-06	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	5.37e-07	5.94e-06	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	5.37e-07	5.94e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.36e-07	5.94e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.36e-07	5.93e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.35e-07	5.92e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.34e-07	5.9e-06	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	5.33e-07	5.9e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.33e-07	5.9e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.33e-07	5.89e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.32e-07	5.89e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	5.31e-07	5.88e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	5.31e-07	5.88e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.29e-07	5.85e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.28e-07	5.84e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.27e-07	5.83e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.25e-07	5.81e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.25e-07	5.81e-06	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.22e-07	5.78e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.19e-07	5.74e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	5.19e-07	5.74e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.18e-07	5.74e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	5.18e-07	5.74e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.17e-07	5.73e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.15e-07	5.7e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.11e-07	5.65e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.1e-07	5.64e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.09e-07	5.63e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.09e-07	5.63e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.07e-07	5.61e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	5.07e-07	5.61e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	5.07e-07	5.61e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	5.06e-07	5.6e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.05e-07	5.59e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.03e-07	5.57e-06	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.03e-07	5.56e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.03e-07	5.56e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	5.01e-07	5.54e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.99e-07	5.53e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.98e-07	5.51e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.98e-07	5.51e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.97e-07	5.5e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.97e-07	5.49e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.96e-07	5.48e-06	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.96e-07	5.48e-06	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.95e-07	5.48e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.94e-07	5.47e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.93e-07	5.45e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.92e-07	5.45e-06	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.92e-07	5.44e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.89e-07	5.41e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.89e-07	5.41e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.88e-07	5.4e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.88e-07	5.4e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.86e-07	5.38e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	4.86e-07	5.38e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	4.85e-07	5.37e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	4.85e-07	5.36e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	4.85e-07	5.36e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.84e-07	5.35e-06	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.82e-07	5.33e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	4.81e-07	5.33e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.77e-07	5.28e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	4.74e-07	5.25e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	4.72e-07	5.23e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.67e-07	5.17e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.64e-07	5.13e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.63e-07	5.13e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.61e-07	5.1e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.58e-07	5.07e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.56e-07	5.05e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	4.56e-07	5.05e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.56e-07	5.04e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.55e-07	5.03e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.54e-07	5.03e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.53e-07	5.02e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.52e-07	5e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.52e-07	5e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.5e-07	4.97e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.48e-07	4.95e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.48e-07	4.95e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.47e-07	4.95e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.47e-07	4.95e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.46e-07	4.94e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.46e-07	4.94e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.45e-07	4.92e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.43e-07	4.9e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.43e-07	4.9e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.39e-07	4.86e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.38e-07	4.84e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.35e-07	4.82e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	4.33e-07	4.79e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.28e-07	4.74e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.27e-07	4.72e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.25e-07	4.7e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.22e-07	4.67e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.21e-07	4.66e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.21e-07	4.66e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.15e-07	4.59e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.14e-07	4.58e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	4.14e-07	4.58e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.07e-07	4.5e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.98e-07	4.4e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	3.96e-07	4.38e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.79e-07	4.19e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	3.79e-07	4.19e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	3.76e-07	4.16e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.72e-07	4.11e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.67e-07	4.06e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.65e-07	4.04e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.64e-07	4.03e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.49e-07	3.87e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.49e-07	3.86e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	3.45e-07	3.82e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.44e-07	3.8e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.43e-07	3.79e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.42e-07	3.78e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	3.41e-07	3.77e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.37e-07	3.73e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.36e-07	3.72e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.34e-07	3.7e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	3.23e-07	3.58e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.22e-07	3.56e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.2e-07	3.54e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.2e-07	3.54e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.17e-07	3.51e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	3.17e-07	3.5e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.16e-07	3.5e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	3.16e-07	3.5e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.15e-07	3.49e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.14e-07	3.48e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.13e-07	3.46e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.11e-07	3.44e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.1e-07	3.43e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.92e-07	3.23e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.88e-07	3.19e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	2.74e-07	3.03e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AKT1—type 2 diabetes mellitus	2.72e-07	3.01e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	2.44e-07	2.7e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.38e-07	2.64e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.25e-07	2.49e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.23e-07	2.46e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.9e-07	2.11e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.47e-07	1.63e-06	CbGpPWpGaD
